With increasing clinical demands for MEK inhibitors in cancer treatment, overcoming
With increasing clinical demands for MEK inhibitors in cancer treatment, overcoming the level of resistance to MEK inhibitors can be an urgent issue to become solved. breast cancer tumor MDA-MB-231 cells. Today’s study not merely revealed which the mevalonate pathway could possibly be targetable to improve the efficiency of MEK inhibitors, but also proposes that … [Read more…]